These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27394029)

  • 1. Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence.
    Stack G; Tormey CA
    Transfusion; 2016 Nov; 56(11):2662-2667. PubMed ID: 27394029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-related red blood cell alloantibodies: induction and consequences.
    Tormey CA; Hendrickson JE
    Blood; 2019 Apr; 133(17):1821-1830. PubMed ID: 30808636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS
    Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease.
    Harm SK; Yazer MH; Monis GF; Triulzi DJ; Aubuchon JP; Delaney M
    Am J Clin Pathol; 2014 Feb; 141(2):256-61. PubMed ID: 24436274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The persistence and evanescence of blood group alloantibodies in men.
    Tormey CA; Stack G
    Transfusion; 2009 Mar; 49(3):505-12. PubMed ID: 19040411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressants and alloimmunization against red blood cell transfusions.
    Zalpuri S; Evers D; Zwaginga JJ; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG
    Transfusion; 2014 Aug; 54(8):1981-7. PubMed ID: 24689865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
    Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell alloimmunization from an African perspective.
    Natukunda B; Brand A; Schonewille H
    Curr Opin Hematol; 2010 Nov; 17(6):565-70. PubMed ID: 20827185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunization in neonates and children up to 3 years of age.
    Türkmen T; Qiu D; Cooper N; Sachs UJ; Wößmann W; Schranz D; Zimmer KP; Ehrhardt H; Hackstein H; Bein G
    Transfusion; 2017 Nov; 57(11):2720-2726. PubMed ID: 28880379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence, immunogenicity, and evanescence of alloantibodies to MUT and Mur antigens of GP.Mur red blood cells in a Southeast Asian patient cohort.
    Nadarajan VS
    Transfusion; 2018 May; 58(5):1189-1198. PubMed ID: 29441590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red Blood Cell Antibodies in Hematology/Oncology Patients: Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies.
    Hendrickson JE; Tormey CA
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):635-51. PubMed ID: 27113001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
    Tormey CA; Fisk J; Stack G
    Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R; Hendrickson JE
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
    Ang AL; Lim CY; Ng WY; Lam JCM
    Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hemolytic transfusion reactions following emergency-release RBC transfusion.
    Goodell PP; Uhl L; Mohammed M; Powers AA
    Am J Clin Pathol; 2010 Aug; 134(2):202-6. PubMed ID: 20660321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study).
    Schonewille H; Honohan Á; van der Watering LM; Hudig F; Te Boekhorst PA; Koopman-van Gemert AW; Brand A
    Transfusion; 2016 Feb; 56(2):311-20. PubMed ID: 26442648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
    Hendrickson JE; Delaney M
    Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.